The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma

Archives of Dermatological Research

Volumn 308, Issue 2, 2016, Pages 133-137

  Redelfs, Lisa ^a   Fischer, Jan ^a   Weber, Clemens ^a   Wu, Zhihong ^a,b   Meyer Hoffert, Ulf ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Actinic keratosis; Desquamation; Inhibitor; Kallikrein; Protease; Squamous cell carcinoma

Indexed keywords

SERINE PROTEASE INHIBITOR OF KAZAL TYPE 9; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; KALLIKREIN; KLK5 PROTEIN, HUMAN; LEUKOCYTE ELASTASE INHIBITOR; SPINK9 PROTEIN, HUMAN;

ACTINIC KERATOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; NEURODERMATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; ANTAGONISTS AND INHIBITORS; CELL CULTURE; EPIDERMIS; METABOLISM; PATHOLOGY;

CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; EPIDERMIS; HUMANS; KALLIKREINS; KERATOSIS, ACTINIC; NEURODERMATITIS; PROTEINASE INHIBITORY PROTEINS, SECRETORY;

EID: 84958041237     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-015-1616-5     Document Type: Article

References (16)

1. Borgono CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 282(6):3640–3652
2. Brattsand M, Stefansson K, Hubiche T, Nilsson SK, Egelrud T (2009) SPINK9: a selective, skin-specific kazal-type serine protease inhibitor. J Invest Dermatol 129(7):1656–1665
3. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206(5):1135–1147
4. Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, Schmidt R, Egelrud T, Simon M, Serre G (2004) Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122(5):1235–1244
5. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25(2):141–142
6. Eissa A, Amodeo V, Smith CR, Diamandis EP (2011) Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J Biol Chem 286(1):687–706
7. Fernandez-Figueras MT, Carrato C, Saenz X, Puig L, Musulen E, Ferrandiz C, Ariza A (2015) Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol 29(5):991–997. doi:10.1111/jdv.12848
8. Hansson L, Backman A, Ny A, Edlund M, Ekholm E, Ekstrand HB, Tornell J, Wallbrandt P, Wennbo H, Egelrud T (2002) Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 118(3):444–449
9. Kantyka T, Fischer J, Wu Z, Declercq W, Reiss K, Schroder JM, Meyer-Hoffert U (2011) Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6. Peptides 32(6):1187–1192. doi:10.1016/j.peptides.2011.03.009
10. Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, Takehara K, Diamandis EP (2005) Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 153(2):274–281
11. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, Saijoh K (2003) Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol 121(3):542–549
12. Magert HJ, Standker L, Kreutzmann P, Zucht HD, Reinecke M, Sommerhoff CP, Fritz H, Forssmann WG (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 274(31):21499–21502
13. Meyer-Hoffert U, Schroder JM (2011) Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc 15(1):16–23. doi:10.1038/jidsymp.2011.2
14. Meyer-Hoffert U, Wu Z, Kantyka T, Fischer J, Latendorf T, Hansmann B, Bartels J, He Y, Glaser R, Schroder JM (2010) Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J Biol Chem 285(42):32174–32181
15. Meyer-Hoffert U, Wu Z, Schroder JM (2009) Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS One 4(2):e4372. doi:10.1371/journal.pone.0004372
16. Simon M, Jonca N, Guerrin M, Haftek M, Bernard D, Caubet C, Egelrud T, Schmidt R, Serre G (2001) Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 276(23):20292–20299